This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: David Chen - Innovator in Cancer Detection
Introduction
David Chen is an accomplished inventor based in Delaware. He has made significant contributions to the field of medical technology, particularly in the detection of cancer. His innovative work focuses on improving diagnostic methods for renal clear cell carcinoma.
Latest Patents
David Chen holds a patent titled "Selective Detection Of Bone Metastases In Renal Clear Cell Carcinoma." This invention pertains to the detection of bone metastases in renal cell carcinoma (RCC) using a 12 4 I-labelled antibody or antigen-binding fragment directed against carbonic anhydrase IX. Although he currently has 0 patents, his research is pivotal in advancing cancer diagnostics.
Career Highlights
David Chen is associated with Heidelberg Pharma AG, a company known for its innovative approaches in the pharmaceutical industry. His work at the company emphasizes the importance of early detection and treatment of cancer, which can significantly improve patient outcomes.
Collaborations
David has collaborated with notable colleagues, including Roman Bartz and Robert Uzzo. These partnerships enhance the research and development efforts within the field of cancer detection.
Conclusion
David Chen's contributions to cancer detection technology highlight his commitment to improving medical diagnostics. His innovative approach and collaboration with esteemed colleagues position him as a valuable asset in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile